Diphenylsulfid-2-sulfonamid | 22172-72-1

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: Diphenylsulfid-2-sulfonamid
• 英文别名: 2-Phenylsulfanylbenzenesulfonamide
• CAS: 22172-72-1
• 化学式: C₁₂H₁₁NO₂S₂
• 分子量: 265.357
• InChiKey: URDPMPGGXZVVPD-UHFFFAOYSA-N

物化性质

• 熔点：
  111 °C
• 沸点：
  433.2±47.0 °C(Predicted)
• 密度：
  1.41±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  93.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  Diphenylsulfid-2-sulfonamid 生成 2-(2-bromophenyl)sulfanylbenzenesulfonamide;2-(4-bromophenyl)sulfanylbenzenesulfonamide
  参考文献：
  名称：

  ABRAMOVITCH R. A.; AZOGU C. I.; MCMASTER I. T.; VANDERPOOL D. P., J. ORG. CHEM. 1978, 43, NO 6, 1218-1226

  摘要：

  DOI：
• 作为产物：
  描述：

  2-氨基苯磺酸 在 potassium phosphate 、 copper(l) iodide 、 新铜试剂 、 sodium carbonate 、 sodium hydroxide 、 sodium nitrite 作用下， 以 水 、 甲苯 为溶剂， 反应 12.0h， 生成 Diphenylsulfid-2-sulfonamid
  参考文献：
  名称：

  Design, synthesis and biological evaluation of benzo[1.3.2]dithiazolium ylide 1,1-dioxide derivatives as potential dual cyclooxygenase-2/5-lipoxygenase inhibitors

  摘要：

  3-(4-Bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide (5) was discovered as a new prototype for dual inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX). Thus, the structure-activity relationships of benzo[1.3.2]dithiazolium ylide 1,1-dioxide skeleton were carried out. The 6-NO2 group played an essential role in the inhibitory activity. In addition, moderate-sized lipophilic substituents at the para-position of the 3-aryl moiety were required for dual COX-2/5-LOX inhibitory activity. Among the identified potent dual inhibitors, 3-(4-tbutylphenyl) derivative 30c (IC50 values of 0.27 mu M and 0.30 mu M against COX-2 and 5-LOX, respectively) and 3-(4-biphenyl) derivative 30f (IC50 values of 0.50 mu M and 0.15 mu M against COX-2 and 5-LOX, respectively) were the most potent dual COX-2/5-LOX inhibitors. Intraperitoneal administration of 30c at 100 mg/kg demonstrated potent acute anti-inflammatory activity. As a result, benzo[1.3.2]dithiazolium ylide 1,1-dioxide represented a novel scaffold for the exploitation in developing dual COX-2/5-LOX inhibitors. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.09.003

文献信息

• Microwave-Assisted Cross-Coupling for the Construction of Diaryl Sulfides
  作者：Chen-Ming Tan、Grace Shiahuy Chen、Chien-Shu Chen、Ji-Wang Chern

  DOI：10.1002/jccs.201190064

  日期：2011.2

  construction of diaryl sulfides through the cross‐coupling of aryl iodides and thiols in microwave heating is described. By using this method, a variety of diaryl sulfides can be prepared in a mild condition and in high yields. Deactivated 4‐nitrothiophenol was effective to afford the product in 94% yield. Sterically hindered ortho‐substituted aryl iodides or thiophenols provided diaryl sulfides effectively

  描述了在微波加热中通过芳基碘化物和硫醇的交叉偶联来构建二芳基硫醚。通过使用这种方法，可以在温和的条件下以高收率制备各种二芳基硫醚。失活的4-硝基硫代苯酚可有效地以94％的收率提供产品。通过微波辅助的偶联反应，受位阻的邻位取代的芳基碘化物或苯硫酚可有效地提供二芳基硫化物。
• [EN] METALLO-BETA-LACTAMASE INHIBITORS<br/>[FR] INHIBITEURS DE MÉTALLO-BÊTA-LACTAMASES
  申请人：MERCK SHARP & DOHME

  公开号：WO2016206101A1

  公开（公告）日：2016-12-29

  The present invention relates to compounds of formula I that are metallo-β-lactamase inhibitors, the synthesis of such compounds, and the use of such compounds for use with β-lactam antibiotics for overcoming resistance.

  本发明涉及一种属于金属β-内酰胺酶抑制剂的I式化合物，以及这种化合物的合成和将其与β-内酰胺类抗生素一起用于克服耐药性的用途。
• Molecular structures of cyclic sulfilimines without and with intramolecular sulfur-oxygen interaction: an X-ray study
  作者：J. Rábai、I. Kapovits、I. Jalsovszky、Gy. Argay、V. Fülöp、A. Kálmán、T. Koritsánszky

  DOI：10.1016/0022-2860(96)09248-4

  日期：1996.8

  3-Phenylbenzo[1.3.2]dithiazolium ylide 1.1 dioxide (1) and its o-methoxycarbonyl derivative (2) have been prepared and their structures established by X-ray crystallography from diffractometer data. Compound 1 (C12H9NO2S2) crystallizes in the triclinic space group P 1 with a = 6.664(1), b = 7.881(1), c = 12.437(2) A , α = 98.81(1), β = 97.44(1), γ = 113.05(1)°, V = 580.9(4) A 3 , Z = 2, Dc = 1.51 g

  摘要 3-苯基苯并[1.3.2]二噻唑鎓叶立德1.1二氧化物(1)及其邻甲氧基羰基衍生物(2)已制备，并通过X射线晶体学从衍射仪数据确定了它们的结构。化合物 1 (C12H9NO2S2) 在三斜空间群 P 1 中结晶，a = 6.664(1), b = 7.881(1), c = 12.437(2) A, α = 98.81(1), β = 97.44(1), γ = 113.05(1)°，V = 580.9(4) A 3 ，Z = 2，Dc = 1.51 g.cm-3 和 μ(CuKα) = 4.00 mm-1。化合物 2 (C14H11NO4S2) 在正交空间群 P212121 中结晶，a = 7.620(1), b = 8.887(1), c = 20.022(2) A , V = 1355.9(5) A 3, Dc = = 1.57 g.cm−3 和 μ(CuKα) = 3.65
• 2-phenoxy- and 2-phenylsulfanyl-benzenesulfonamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
  申请人：Actimis Pharmaceuticals, Inc.,

  公开号：EP1997495A1

  公开（公告）日：2008-12-03

  The present invention relates to a benzenesulfonamide derivative of formula (I), which is useful as an active ingredient of pharmaceutical preparations. The benzenesulfonamide derivatives of the present invention have CCR3 (CC type chemokine receptor) antagonistic activity, and can be used for the prophylaxis and treatment of disease associated with CCR3 activity, in particular for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders. wherein X represents O or S; R4 represents the other substituents are as defined in claim 1.

  本发明涉及一种式（I）的苯磺酰胺衍生物，可用作药物制剂的活性成分。本发明的苯磺酰胺衍生物具有 CCR3（CC 型趋化因子受体）拮抗活性，可用于预防和治疗与 CCR3 活性相关的疾病，特别是用于治疗哮喘、特应性皮炎、过敏性鼻炎和其他炎症/免疫性疾病。 其中 X 代表 O 或 S R4 代表 其他取代基如权利要求 1 所定义。
• Intramolecular cyclizations of sulfonyl nitrenes
  作者：Rudolph A. Abramovitch、C. I. Azogu、I. T. McMaster

  DOI：10.1021/ja01033a033

  日期：1969.2